Houte Hans Van
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $635K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 4SEC | NRIXNurix Therapeutics, Inc. | Sell Plan | 1,79443,133 held (−4%) | $23.89 | $43K | -6.4% |
| Aug 4SEC | NRIXNurix Therapeutics, Inc. | Sell Plan | 2,96740,166 held (−7%) | $24.65 | $73K | -9.3% |
| Jul 30SEC | NRIXNurix Therapeutics, Inc. | Sell | 2,84544,927 held (−6%) | $23.38 | $67K | -4.4% |
| May 5SEC | NRIXNurix Therapeutics, Inc. | Sell Plan | 13,47338,174 held (−26%) | $16.58 | $223K | +34.8% |
| May 5SEC | NRIXNurix Therapeutics, Inc. | Sell Plan | 58237,592 held (−2%) | $17.18 | $10K | +30.1% |
| Apr 30SEC | NRIXNurix Therapeutics, Inc. | Sell | 2,38851,647 held (−4%) | $16.65 | $40K | +34.2% |
| Jan 30SEC | NRIXNurix Therapeutics, Inc. | Sell | 3,58845,500 held (−7%) | $16.58 | $59K | +34.8% |
| Jan 30SEC | NRIXNurix Therapeutics, Inc. | Sell | 7345,427 held (−0%) | $17.37 | $1K | +28.7% |
| Nov 3SEC | NRIXNurix Therapeutics, Inc. | Sell Plan | 6,28437,592 held (−14%) | $12.56 | $79K | +77.9% |
| Oct 30SEC | NRIXNurix Therapeutics, Inc. | Sell | 3,13043,876 held (−7%) | $12.80 | $40K | +74.6% |
- Sell
CFO Houte Hans Van sold $43K of NRIX at $23.89 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Houte Hans Van sold $73K of NRIX at $24.65 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Houte Hans Van sold $223K of NRIX at $16.58 — cuts the stake by 26%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Houte Hans Van sold $10K of NRIX at $17.18 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Houte Hans Van sold $79K of NRIX at $12.56 — pre-scheduled 10b5-1 plan sale.